CEMEC - Centro Multidisciplinar de Estudos Clínicos
CEMEC - Centro Multidisciplinar de Estudos Clínicos
R. Silva Jardim, 187 - 63 - Centro, São Bernardo do Campo - SP, 09715-090, Brazil
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Licia Carmo
Ricardo Carmo
Gabrielle Martins Arantes da Silva
Giovanna Jasmine Lopes
Murilo Ferriani Ribeiro
Miriam Souza
Claudia Domingues
Gabriel Berthi
Adriana Rodrigues de Paula
Emerson Gisoldi
Arianni Petta
Paula Rodrigues
Mayla Silva
Fernanda Kawamoto
Silvia Pinheiro
Cintia de Azevedo M. Perico
Debora Cruz
Livia Souza
Sidilene Mata
Ester Moreira
Patricia Wandscher
Dalila Silva
Anna Maura Fernandes
Ingrid de Oliveira
Danyela Souza
Andrea Pez
Millena Assunção
Italo Giovanni Bonatto
Thiago de Magalhães Lopes
Flavio Correia
Matheus Pereira
Danilo Bortolotto Gurian
Henrique Silva
Giovanna Tambellini
Pedro Monari
Joao Antonio Correa
Camila Cavalcante Koury
Eliane Fuji
Open studies
Cardiovascular disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer IngelheimSee more
Pulmonary fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers SquibbSee more
Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
